A pharmaceutical company is recalling medication for ADHD (attention deficit hyperactivity disorder) and narcolepsy because packages of the drug may contain the wrong pills, the U.S. Food and Drug Administration is reporting.
The product is being recalled after a pharmacist in Nebraska opened a bottle of Zenzedi tablets and found tablets of Carbinoxamine Maleate, an antihistamine drug, the federal drug agency announced in a Jan. 24 recall.
Zenzedi is used to treat narcolepsy, a sleep disorder, and also sometimes used as a treatment for ADHD.
Upon learning of the incident, the FDA wrote, the manufacturer, Woburn, Massachusetts-based Azurity Pharmaceuticals , opened a product complaint and an investigation.
The company then immediatly sent recall notification letters via overnight delivery to wholesale distributors, the FDA reported.
What else is being recalled? Check USA TODAY’s recall database
What ADHD medication is being recalled?
Azurity Pharmaceuticals is voluntarily recalling one lot of Zanzedi 30 mg with lot number F230169A.